In patients with mild Alzheimer's disease solanezumab, an antibody designed to facilitate clearance of amyloid-beta plaques, did not significantly reduce cognitive decline over time.
A higher incidence of subdural hematomas is associated with the increased use of antithrombotic drugs, particularly vitamin k antagonists among older patients.
Cannabis health end points include therapeutic effects, cardiometabolic risk, mental health, respiratory disease, and substance abuse.
The potency of synthetic cannabinoids is consistent with strong depressant effects that account for "zombie-like" behavior.
Grapefruit can safely be consumed with the majority of medications, and patients with concerns should consult with their physicians.
Research suggests that injecting lidocaine with epinephrine may not be as dangerous as previously thought.
A patient was diagnosed with a serum sickness-like reaction in response to antibiotics.
A Bronx jury awarded close to $120 million to a woman who suffered brain damage after being treated at three New York area hospitals.
Taking boceprevir with ritonavir-boosted HIV protease inhibitors together reduces the effectiveness of both therapies, the FDA announced.
What are the differential diagnoses for a woman aged 60 years with a metallic taste in her mouth and the sensation of a burning tongue?
A patient taking terbinafine for onychogryphosis developed a fine pruritic rash over sun exposed body areas while on vacation. Could the drug be to blame?
Read this tip for making abstract concepts, like converting metric medication doses, go down smoothly.
The FDA is updating boxed warnings on all tumor necrosis factor-alpha inhibiting drugs to reflect risk for infection with the bacteria Legionella and Listeria.
The FDA is warning health care providers about reports of type 1 hypersensitivity reactions among patients taking the antipsychotic asenapine maleate (Saphris), with some cases occurring at first dose.
Nonsteroidal anti-inflammatory drugs have been linked with increased risk for atrial fibrillation and adverse events in patients with hypertension and coronary artery disease.
An estimated 70% of all U.S. cancer cases diagnosed in 2030 will be among older adults, and the risk of adverse drug reactions and interactions will undoubtedly rise as more elderly patients are prescribed multiple medications.
The FDA lowered the maximum dose of the antidepressant citalopram hydrobromide (Celexa) from 60 mg per day to 40 mg per day, after concerns that higher doses of the medication increase the risk for cardiac arrhythmia without offering therapeutic benefits.
While it is true that lower serum ethinyl estradiol and progestin levels have been found in women using combination OCs and antibiotics, these women remain well within the therapeutic window.
How concerned should clinicians be about serotonin syndrome when prescribing a triptan with a selective serotonin reuptake inhibitor (SSRI)?
What is the appropriate workup in an otherwise healthy woman aged 75 years with new-onset hair loss?
Is it possible to have a geriatric patient in serious delirium while all labs and urinalysis are within normal limits?
Before prescribing medications to control diabetes, clinicians should consider potential adverse events and drug interactions.
Interim findings from an epidemiological study involving 193,099 patients with diabetes showed that using pioglitazone longer than one year increased patients' risk for bladder cancer.
Clinicians should not administer methylene blue or linezolid, two reversible monoamine oxidase inhibitors (MOAIs), to patients taking selective serotonin reuptake inhibitors (SSRIs) due to risk for serious central nervous system reactions.